VO2 Max in Clinical Cardiology: Clinical Applications, Evidence Gaps, and Future Directions
- 01-12-2025
- Cardiac Amyloidosis
- Cardiometabolic Disease (DM and CV) (CJ Lavie, Section Editor)
- Authors
- Hesham M. Abdalla
- Luke Dreher
- Hunter VanDolah
- Adam Bacon
- Mohammed El-Nayir
- Mahmoud Abdelnabi
- Ramzi Ibrahim
- Hoang Nhat Pham
- George Bcharah
- Girish Pathangey
- Courtney Wheatley-Guy
- Satyajit Reddy
- Juan Farina
- Chadi Ayoub
- Reza Arsanjani
- Published in
- Current Cardiology Reports | Issue 1/2025
Abstract
Purpose of Review
VO₂ max is a fundamental marker of cardiorespiratory fitness with substantial prognostic and diagnostic value within the field of cardiology. This review analyzes current and emerging evidence regarding its clinical uses, highlights key evidence gaps, and explores emerging developments poised to broaden its clinical application.
Recent Findings
Evidence supports VO2 max as a powerful independent predictor for heart failure, coronary artery disease, hypertrophic cardiomyopathy, and cardiac amyloidosis, supporting it use in identifying high-risk patients for advanced interventions. Recent developments including the integration of machine learning and wearable devices can facilitate accurate VO2 estimation in routine clinical practice without the necessity of specialized diagnostic tools.
Summary
Despite its robust diagnostic and prognostic value, VO₂ max assessment remains underutilized in routine cardiovascular care, primarily due to the need for specialized equipment and personnel. Future research should explore emerging technological innovations for VO2 max estimation and the development of evidence-based protocols to support its broader clinical implementation for improved cardiovascular outcomes.
Graphical Abstract
Advertisement
- Title
- VO2 Max in Clinical Cardiology: Clinical Applications, Evidence Gaps, and Future Directions
- Authors
-
Hesham M. Abdalla
Luke Dreher
Hunter VanDolah
Adam Bacon
Mohammed El-Nayir
Mahmoud Abdelnabi
Ramzi Ibrahim
Hoang Nhat Pham
George Bcharah
Girish Pathangey
Courtney Wheatley-Guy
Satyajit Reddy
Juan Farina
Chadi Ayoub
Reza Arsanjani
- Publication date
- 01-12-2025
- Publisher
- Springer US
- Keywords
-
Cardiac Amyloidosis
Heart Failure - Published in
-
Current Cardiology Reports / Issue 1/2025
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170 - DOI
- https://doi.org/10.1007/s11886-025-02289-6
This content is only visible if you are logged in and have the appropriate permissions.